Case Report: Immune checkpoint inhibitor–induced multiorgan vasculitis successfully treated with rituximab

Case Report: Immune checkpoint inhibitor–induced multiorgan vasculitis successfully treated with rituximab

Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of cancer. ICIs have a unique side effect profile, generally caused by inflammatory tissue damage, with clinical features similar to autoimmune conditions. Acute kidney injury from ICIs has been well studied; incidence ranges from...

Full description

Bibliographic Details
Main Authors: Sehrish Qureshi, Naszrin Arani, Vishnu Parvathareddy, Amanda Tchakarov, Maen Abdelrahim, Maria Suarez-Almazor, Jianjun Zhang, Don Lynn Gibbons, John Heymach, Mehmet Altan, Ala Abudayyeh
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-07-01
Series:Frontiers in Nephrology
Subjects:
immune check inhibitor
autoimmune induction
vasculitis
acute renal failure
rituximab
Online Access:https://www.frontiersin.org/articles/10.3389/fneph.2023.1168614/full

Internet

https://www.frontiersin.org/articles/10.3389/fneph.2023.1168614/full

Similar Items